Capstone Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$4.58M Sell
74,821
-3,190
-4% -$194K 0.13% 198
2017
Q1
$4.73M Buy
78,011
+1,320
+2% +$80.1K 0.13% 187
2016
Q4
$4.31M Buy
76,691
+4,366
+6% +$256K 0.12% 201
2016
Q3
$4.31M Buy
72,325
+7,333
+11% +$429K 0.12% 191
2016
Q2
$3.57M Buy
64,992
+2,233
+4% +$119K 0.11% 216
2016
Q1
$3.17M Buy
62,759
+11,092
+21% +$543K 0.09% 277
2015
Q4
$2.6M Buy
51,667
+7,109
+16% +$358K 0.08% 313
2015
Q3
$2.1M Buy
44,558
+1,344
+3% +$71.4K 0.07% 352
2015
Q2
$2.35M Sell
43,214
-54,592
-56% -$3.06M 0.07% 340
2015
Q1
$5.36M Buy
97,806
+3,057
+3% +$173K 0.15% 166
2014
Q4
$5.13M Sell
94,749
-2,680
-3% -$149K 0.15% 171
2014
Q3
$5.51M Sell
97,429
-1,082
-1% -$60.8K 0.19% 125
2014
Q2
$5.44M Sell
98,511
-72,798
-42% -$3.97M 0.17% 139
2014
Q1
$9.28M Sell
171,309
-83,666
-33% -$4.33M 0.28% 73
2013
Q4
$12.2M Sell
254,975
-174,249
-41% -$7.97M 0.35% 43
2013
Q3
$19.5M Sell
429,224
-17,215
-4% -$786K 0.47% 30
2013
Q2
$19.8M Buy
+446,439
New +$19.9M 0.52% 26

Other funds holding MRK

Capstone Asset Management's MRK Position: Q2 2017 in Review

Capstone Asset Management reduced its Merck (MRK) stake by 4.1% in Q2 2017, selling an estimated $194K and leaving 74,821 shares worth $4.58M. The position accounts for 0.13% of the portfolio, ranked #198.

Capstone Asset Management first reported a position in MRK in Q2 2013 and has held it in 17 quarters since. The position peaked at $19.8M in Q2 2013. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Capstone Asset Management held 74,821 shares of Merck worth $4.58M as of Q2 2017.
  • Capstone Asset Management sold 3,190 Merck shares in Q2 2017, an estimated $194K.
  • Merck made up 0.13% of Capstone Asset Management's portfolio in Q2 2017, its #198 holding.
  • Capstone Asset Management first reported a position in Merck in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Merck position peaked at $19.8M in Q2 2013.
  • 1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.